YIH
CGEM icon

Y-Intercept (HK)’s Cullinan Oncology CGEM Stock Holding History

Y-Intercept (HK)’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
80,648
-14,769
-15% -$219K 0.03% 867
2026
Q1 		$1.36M Buy
+95,417
New +$1.23M 0.03% 906
2025
Q3 		– Sell
-11,129
Closed -$83.8K – 1610
2025
Q2 		$83.8K Buy
+11,129
New +$89.4K ﹤0.01% 1545
2024
Q4 		– Sell
-25,369
Closed -$425K – 1244
2024
Q3 		$425K Buy
25,369
+7,343
+41% +$130K 0.03% 851
2024
Q2 		$314K Buy
+18,026
New +$384K 0.02% 1022

Other funds holding CGEM

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return